AKAM vs HQY: stock comparison and AI forecast
Akamai Technologies Inc (AKAM) and Healthequity, Inc. (HQY) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
AKAM Akamai Technologies Inc
- Market Cap
- $11.94B
- P/E Ratio
- 31.0x
- Size
- large-cap
- AI Forecast
HQY Healthequity, Inc.
- Market Cap
- $8.57B
- P/E Ratio
- 40.5x
- Size
- mid-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- AKAM is 1.4 times larger than HQY by market capitalization ($11.94B against $8.57B).
- AKAM trades at 31.0 times trailing earnings, HQY at 40.5 times.
- HQY turns 17.4% of its revenue into net income, against 8.8% for AKAM.
- AKAM carries 2.02 times debt per unit of equity, against 0.64 times for HQY.
- Both companies share the SEC industry classification Services-Business Services, NEC.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | AKAM | HQY |
|---|---|---|
| Market Cap | $11.94B | $8.57B |
| P/E Ratio | 31.00x | 40.48x |
| P/B Ratio | 2.32x | 4.31x |
| EPS | $2.68 | $2.56 |
| Book Value/Share | $35.82 | $24.06 |
| Revenue/Share | $30.55 | $16.47 |
| FCF/Share | $3.79 | $5.90 |
Profitability & Margins
| Metric | AKAM | HQY |
|---|---|---|
| ROE | 7.5% | 11.9% |
| ROA | 2.5% | 7.2% |
| ROIC | 3.0% | 11.3% |
| Gross Margin | 56.4% | 71.2% |
| Operating Margin | 9.1% | 25.8% |
| Net Margin | 8.8% | 17.4% |
| EBT Margin | 10.6% | 22.7% |
| Tax Rate | 16.5% | 23.4% |
Financial Health
| Metric | AKAM | HQY |
|---|---|---|
| Current Ratio | 2.13x | 2.99x |
| D/E Ratio | 2.02x | 0.64x |
| Financial Leverage | 3.02x | 1.64x |
| Interest Coverage | 10.2x | 4.2x |
| Working Capital | $2.55B | $306M |
Cash Flow
| Metric | AKAM | HQY |
|---|---|---|
| Operating Cash Flow | $1.44B | $490M |
| Free Cash Flow | $545M | $488M |
| Capital Spending | -$893M | -$2M |
| OCF Growth YoY | -3.9% | 33.6% |
| FCF Growth YoY | -46.9% | 33.5% |
| FCF/Sales | 12.4% | 35.8% |
| CapEx/Sales | 20.4% | 0.2% |
Operational Efficiency
| Metric | AKAM | HQY |
|---|---|---|
| Asset Turnover | 0.28x | 0.42x |
| Receivables Turnover | 4.6x | 11.2x |
| Fixed Assets Turnover | – | 282.4x |
| Days Sales Outstanding | 80 days | 33 days |
| Payables Period | 39 days | 8 days |
Income Statement
| Metric | AKAM | HQY |
|---|---|---|
| Total Revenue | $4.39B | $1.36B |
| Operating Income | $398M | $351M |
| Net Income | $388M | $236M |
| R&D Expense | $571M | $278M |
| SG&A Expense | $2.46B | $397M |
| Cost of Goods Sold | $1.91B | $392M |
Dividend & Shareholder Information
| Metric | AKAM | HQY |
|---|---|---|
| Shares Outstanding | 144M | 83M |
| Net Income Growth | -23.5% | 62.2% |
| EPS Growth | 3.1% | 86.9% |
AKAM vs HQY: stock comparison and AI forecast
Which is bigger, AKAM or HQY?
AKAM is 1.4 times larger than HQY by market capitalization ($11.94B against $8.57B).
Which is cheaper on earnings, AKAM or HQY?
AKAM trades at 31.0 times trailing earnings, HQY at 40.5 times.
Which one does Intratio's AI model rank higher, AKAM or HQY?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
More comparisons
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.